Note: Ingredients listed on restricted chemical lists
EC/CAS
200-334-9/57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
<20% <75%
General Information
Version
3.0, 11.01.2017
Revision date
2017-01-11
Product name
ORENCIA (abatacept) Subcutaneous Injection, 125 mg/ml
Product Synonyms
Abatacept Injection, Subcutaneous; CTLA-4 Ig Injection, Subcutaneous; CTLA-4
1.2.1 Relevant identified uses
This material is a finished drug product for patient use. It is used to treat autoimmune disorders. It is a protein
Icons in SDS
Company Information
company name
USA
e-mail address of the competent person responsible for the Safety Data Sheet
MG-GBS-MSDS-Request@bms.com
Section 2
SECTION 2: Hazards identification
Classification and Labelling Common to All Jurisdictions
2.1 Classification of the substance or mixture
Not Rated Substance not fully tested.
Precautionary statements
Avoid ingestion, inhalation, and eye contact. Wash hands after handling to minimize exposure. Handle as a potentially hazardous material.
Further information
0.03% of the mixture consists of ingredient(s) of unknown acute toxicity. 29.5% of the mixture consists of ingredients(s) of unknown hazards to the aquatic environment.
